Article
Protein-losing enteropathy as a new phenotype in atypical hemolytic uremic syndrome caused by CD46 gene mutation and recovery from chronic kidney failure by eculizumab treatment
2024-03-12
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic microangiopathies. Genetic defects in complement alternative pathway have been identified in 60-70% of aHUS individuals. Eculizumab is recommended as first-line therapy. <bold>Methods</bold>: We collected clinical data of a pediatric aHUS case, who accompanied with protein-losing enteropa...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 83097d97-e3d2-5777-b782-e9b901cc5bc7
- DOI
- 10.21203/rs.3.rs-4019102/v1
